Cancer Models Forum

Posted by Repositive, September 2018

Two months, three countries, four cities: five translational oncology community-building events

As a social enterprise we work hard to develop the tech tools that will increase discovery of, access to, and sharing of genomic research data – to make life easier for researchers and, ultimately, to benefit patients. But as well as creating two successful products to date, we also place a high premium on building an engaged community in translational oncology.

Only through collaboration and co-operation will substantial break-throughs be achieved so, as part of our commitment to community building, we are taking Repositive on tour.

We’ll be attending five key events in four different cities across three countries over the next two months. We want to make new contacts with as many people involved in pre-clinical cancer research as possible, and we want to reconnect with our existing network across cancer research and genomics. Most importantly, we want to start essential conversations around what more we can do to support better and faster research of cancer cures.

If you will be attending any of the following events and would like to connect with us please email or get in touch on Twitter or LinkedIn.

1 October | Cambridge, UK | Milner Therapeutics Symposium 2018 Anaid Diaz will be presenting a poster at the event and hoping to connect with tech experts and representatives from biopharma and CROs. The symposium will be a great platform to discuss the latest academic and clinical research and its applications in the pharma and biotech industry to develop new treatments. She’ll be ready to share Repositive’s insights about what makes good pre-clinical oncology models. Contact Anaid ahead of the event here.

1-3 October | Weggis, Switzerland | EuroPDX Workshop 2018 Sam Shelton will be at the event each day presenting a poster, and will be speaking at 4.30pm on Tuesday 2 October about PDX initiatives (with thanks to session sponsor, Xentech). Sam hopes to meet with CROs and researchers, and always welcomes an opportunity to talk to CROs looking to list on Repositive, as well as biotechs searching for the ideal model! He’ll be ready to start conversations about humanisation of mouse models, development of standards in PDX, and use of ex vivo/in vitro models to predict in vivo drug responses. Contact Sam ahead of the event here.

3-5 October | Basel, Switzerland | Genome Alliance for Genomics & Health Adrian Alexa, Repositive’s VP of innovation, will be at the event for the duration, hoping to meet researchers and tech experts and soaking up the discussion points raised in the event’s talks. He is particularly looking forward to GenoPri on day one, and to catching up with friends from across the sector throughout the week.

13-16 November | Dublin, Ireland | EORTC-NCI-AACR 2018 Dublin The Repositive team will have a full presence at EORTC-NCI-AACR 2018 Dublin – situated at Booth B6 – and is hosting an industry showcase and networking event for anyone involved in translational oncology at the Dublin Convention Centre on Wednesday 14 November, from 7pm. The team is eager to meet researchers and representatives from CROs – make an appointment by emailing or drop by the booth at any time for a chat, refreshments, and a chance to learn about some of the exciting work that Repositive is supporting in translational oncology.

28-29 November | Basel, Switzerland | BioData 2018 Join the team at their booth throughout the two day event, where we’ll be hoping to connect with tech experts, and discover emerging technologies and innovative practices around the use of genomic data in the biotech industry. A number of interviews with conference speakers are being conducted by Repositive to explore innovation in the biotech industry, and will be published in the lead up to and during the event – keep an eye on our blog for the posts! To arrange to meet, email the team on

To keep up to date with Repositive’s event schedule and blogs, sign up to our mailing list for the latest developments.

Posted by


Repositive Press Team
See all Repositive's posts